The Commission published their proposals for the updating of the veterinary medicines and feed medications legislation in Europe in September, five years after starti...
The Canadian animal pharmaceutical industry represents approximately 2.5% of the global industry, within the world’s second largest land mass (larger than the US), wh...
Tom Overbay of Expedite Animal Health looks into the process of developing and registering products for use in veterinary medicine, often viewed as a quick path to re...
The UK's membership of the European Union (EU) is often a topic of heated debate. While some political parties are enthusiastically in favour of a continued membershi...
The animal health market has demonstrated a recession-proof nature uncommon to most industries. Given the attractiveness of the veterinary market, a number of innovat...
In the world of human health, the increased call for establishing a clear and traceable pedigree for pharmaceutical supply chain had driven the US government to take ...
The central figure in any clinical trial is the investigator. But whilst every investigator is a veterinarian, not every veterinarian makes a good investigator. Denny...
Antibiotics are needed in pets and food animals, just as in humans, but efficacy is compromised through antimicrobial resistance and no new antibiotic molecules. The ...
The introduction of new pharmaceutical veterinary products is dependent on a wide range of activities, through development and manufacturing to clinical field trials ...
The last decade has witnessed a surge in the number of dedicated animal health CROs, labs and consulting organisations, pan-US and EU. In his paper, Vivek C of Beroe ...